Search research articles
Contact Us
Filters
Showing results (111-120 of 162) with videos related to
Page
of 17
Sort By:
The Canadian Journal of Urology
|
August 13, 2015
Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma
Pranav Sharma, Einar F Sverrisson, Kamran Zargar-Shoshtari, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 9, 2020
Focal bipolar radiofrequency ablation for localized prostate cancer: Safety and feasibility
Ahmet Murat Aydin, Kenneth Gage, Jasreman Dhillon, et al.
Clinical Genitourinary Cancer
|
January 3, 2022
Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients' Voice or a Missed Opportunity
Juskaran Chadha, Jacob J Adashek, Heather Jim, et al.
BMC Anesthesiology
|
November 5, 2018
Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral center
Juan Chipollini, Brandon Alford, David C Boulware, et al.
Journal of Kidney Cancer and VHL
|
March 23, 2017
Displacement of the Spleen Mimicking Renal Cell Cancer Recurrence Post-Nephrectomy: A Case Report
Carolina S Emanuels, Krista D Timmerman, Tabish Aijaz, et al.
Current Oncology (Toronto, Ont.)
|
March 28, 2023
Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension
Prithvi B Murthy, Shreyas Naidu, Facundo Davaro, et al.
European Urology Oncology
|
July 16, 2025
Assessing the Impact of Treatment Timing Protocols in Clinical Trials for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer
Christopher Guske, Seyed Behzad Jazayeri, Christian Harrs, et al.
Urology
|
April 5, 2016
Change in Management Based on Pathologic Second Opinion Among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical Practice
Adam M Luchey, Neil J Manimala, Shohreh Dickinson, et al.
Clinical Genitourinary Cancer
|
June 4, 2018
Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional Experience
Charles C Peyton, Mounsif Azizi, Juan Chipollini, et al.
The Journal of Urology
|
October 23, 2020
Reply By Authors
Ali Hajiran, Mounsif Azizi, Ahmet M Aydin, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 162) with videos related to
Sort By:
Page
of 17
The Canadian Journal of Urology
|
August 13, 2015
Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma
Pranav Sharma, Einar F Sverrisson, Kamran Zargar-Shoshtari, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 9, 2020
Focal bipolar radiofrequency ablation for localized prostate cancer: Safety and feasibility
Ahmet Murat Aydin, Kenneth Gage, Jasreman Dhillon, et al.
Clinical Genitourinary Cancer
|
January 3, 2022
Evaluation of Patient-Reported Outcomes (PROs) Protocol Content and Reporting for Clinical Trials that Lead to the approval of frontline Immune Checkpoint Blockade Combination for Patients with Advanced Renal Cell Carcinoma - The Patients' Voice or a Missed Opportunity
Juskaran Chadha, Jacob J Adashek, Heather Jim, et al.
BMC Anesthesiology
|
November 5, 2018
Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral center
Juan Chipollini, Brandon Alford, David C Boulware, et al.
Journal of Kidney Cancer and VHL
|
March 23, 2017
Displacement of the Spleen Mimicking Renal Cell Cancer Recurrence Post-Nephrectomy: A Case Report
Carolina S Emanuels, Krista D Timmerman, Tabish Aijaz, et al.
Current Oncology (Toronto, Ont.)
|
March 28, 2023
Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension
Prithvi B Murthy, Shreyas Naidu, Facundo Davaro, et al.
European Urology Oncology
|
July 16, 2025
Assessing the Impact of Treatment Timing Protocols in Clinical Trials for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer
Christopher Guske, Seyed Behzad Jazayeri, Christian Harrs, et al.
Urology
|
April 5, 2016
Change in Management Based on Pathologic Second Opinion Among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical Practice
Adam M Luchey, Neil J Manimala, Shohreh Dickinson, et al.
Clinical Genitourinary Cancer
|
June 4, 2018
Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional Experience
Charles C Peyton, Mounsif Azizi, Juan Chipollini, et al.
The Journal of Urology
|
October 23, 2020
Reply By Authors
Ali Hajiran, Mounsif Azizi, Ahmet M Aydin, et al.
Page
of 17